
1. antimicrob agents chemother. 2015 mar;59(3):1818-21. doi: 10.1128/aac.03956-14.
epub 2015 jan 12.

molecular characterization cytochrome b gene vitro atovaquone
susceptibility plasmodium falciparum isolates kenya.

ingasia la(1), akala hm(1), imbuga mo(2), opot bh(1), eyase fl(1), johnson jd(1),
bulimo wd(1), kamau e(3).

author information: 
(1)department emerging infectious diseases-global emerging infections
surveillance response system (deid-geis) program, u.s. army medical research 
unit-kenya (usamru-k), kenya medical research institute (kemri)-walter reed
project, kisumu, kenya.
(2)department biochemistry, college health sciences, jomo kenyatta
university agriculture technology, nairobi, kenya.
(3)department emerging infectious diseases-global emerging infections
surveillance response system (deid-geis) program, u.s. army medical research 
unit-kenya (usamru-k), kenya medical research institute (kemri)-walter reed
project, kisumu, kenya edwin.kamau.mil@mail.mil.

the prevalence genetic polymorphism(s) codon 268 cytochrome b
gene, associated failure atovaquone-proguanil treatment, was
analyzed 227 plasmodium falciparum parasites western kenya. the
prevalence wild-type allele 63%, y268s (denoting a
y-to-s change position 268) mutant allele 2%. pure y268c 
y268n mutant alleles, mixtures mutant allele(s) wild type.
there correlation parasite 50% inhibitory concentration (ic50) 
parasite genetic polymorphism; mutant alleles higher ic50s wild
type.

copyright Â© 2015, american society microbiology. rights reserved.

doi: 10.1128/aac.03956-14 
pmcid: pmc4325819
pmid: 25583715  [indexed medline]

